Production & Manufacturing

The biopharmaceutical sector is being revolutionized by the demand for efficiency, increased safety, and sustainability. The core of this revolution is one of the greatest innovations in contemporary manufacturing single-use technologies in biopharma (SUTs). SUTs have changed the way...

Sterility and Cross-Contamination: The Cornerstones of Modern Biopharma Manufacturing Biopharmaceutical production is all about sterility, accuracy, and safety. The risks are too high—patients who depend on these life-saving drugs expect nothing but the best, and sterility failure of any sort...

Green chemistry is a cutting-edge scientific discipline that focuses on developing environmentally friendly and sustainable chemical processes.  In the pharmaceutical industry, it has been gaining significant interest. Green chemistry in EU is transforming the production and usage of pharmaceutical...

Drug development in the European pharmaceutical industry is undergoing a dramatic shift, largely due to the repurposing and reformulation of pre-existing chemicals rather than the discovery of novel molecules.   Advances in specialty intermediates, which are essential for repurposing...

Pharma specialty chemicals companies have been experiencing serious challenges based on the greening regulations enforced by the European Union. Such regulatory systems promote the harmonization of environmental stewardship and industrial development, yet they have become complex for the specialty...

The Indian pharma sector has seen 8% CAGR growth and at the same time has witnessed a 9% rise when it comes to export rates in 2024, as per one of the reports. McKinsey & Company’s report has shown...

LINDIS Biotech has received EMA Marketing Authorisation for catumaxomab, making it the only medicine licensed for the targeted and cancer-directed therapy of malignant ascites. Celonic Group will produce catumaxomab for commercial use. Catumaxomab will be manufactured at Celonic's...